rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Geoffrey Michael Glass

Director

Company insider

Files Form 4 as: Director, Avadel Pharmaceuticals; President, Banner Life Science, Patheon.

Every Form 4 they filed

In numbers

Trades disclosed
55
Buys
9
Sells
0
Bought
$813K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
18 Jun 2012
Last trade
12 Feb 2026
Last filed
12 Feb 2026

Companies traded

Where they are an officer
PatheonOfficer · last 11 Mar 20140 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Avadel PharmaceuticalsDirector · Biotechnology · last 12 Feb 20269 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Feb 2026filed 12 Feb 2026Avadel PharmaceuticalsBiotechnologySEC FORM 4 Code D$462K22,005 at $21.00filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—11,000filing
12 Feb 2026filed 12 Feb 2026Avadel PharmaceuticalsBiotechnologySEC FORM 4 Code D$1.5M69,075 at $21.00filing
12 Feb 2026filed 12 Feb 2026Avadel PharmaceuticalsBiotechnologySEC FORM 4 Code D$1.6M75,904 at $21.00filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—60,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—42,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—42,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—42,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—33,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—11,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—11,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—60,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—42,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—42,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—42,000filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—33,000filing
12 Feb 2026filed 12 Feb 2026Avadel PharmaceuticalsSEC FORM 4 Code D$462K22,005 at $21.00filing
12 Feb 2026filed 12 Feb 2026Avadel PharmaceuticalsSEC FORM 4 Code D$1.5M69,075 at $21.00filing
12 Feb 2026filed 12 Feb 2026Avadel PharmaceuticalsSEC FORM 4 Code D$1.6M75,904 at $21.00filing
12 Feb 2026filed 12 Feb 2026Avadel Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—11,000filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.